Some features of the immune system response in the new coronavirus infection COVID-19

Abstract

AIM: to study the cytokine link of immunity in patients with the new coronavirus infection COVID-19 and the possibility of using these data to predict the risk of lung tissue damage.

MATERIALS AND METHODS: Patients with diagnosed new coronavirus infection COVID-19 were divided into 4 groups depending on the severity of the disease: 1 — asymptomatic patients; 2 — patients with lung tissue damage in the amount of 25%; 3 — patients with lung tissue damage 50%; 4 — patients with lung tissue damage 75% (according to the results computed tomography). Immunological studies were performed upon admission to the clinic, then after 7 days and before discharge. The concentration of cytokines in blood serum was studied by the method of solid-phase enzyme immunoassay using kits manufactured by Vector Best.

RESULTS: In all groups, a low content of proinflammatory cytokines was found: tumor necrosis factor and interferon-γ, interleukin-1, interleukin-2. The median level of interleukin-6 in all groups during the entire follow-up period was within the normal range, however, in some patients there was a multiple excess of its concentration. In groups with 50% and 75% lung tissue damage, an increase in the concentration of interleukin-8 was shown. Statistically significant differences were noted only for the level of interleukin-8 between the group with an asymptomatic form of infection and the CT-2 and CT-3 groups. It was found that the concentration of interleukin-1 below 3.58 pg/ml is a significant risk factor for severe disease. In all groups of subjects, low levels of interleukin-4 and interleukin-10 were noted, while there was no significant difference between the groups. Positive correlations were revealed between the degree of lung tissue damage and the level of interleukins 6, 2 and 8. Negative correlations were established between the degree of lung tissue damage and the content of interleukin-1.

CONCLUSION: There was no significant activation of the cytokine link of adaptive antiviral immunity in the examined contingent. Serum cytokine levels were within normal values and had no significant intergroup differences. An increase in IL-8 in groups with clinically pronounced signs of infection indicates the activation of indicators characterizing innate immunity.

Keywords

anti-inflammatory cytokines / asymptomatic course / COVID-19 / cytokine profile / lung tissue lesion / pro-inflammatory cytokines / T-cells

References

[1] Azarov II, Ovchinnikov DV, Kuzin AA, et al. Assessment of post-vaccination collective immunity against new coronavirus infection (COVID-19) among servicemen of the Armed Forces of the Russian Federation. Bulletin of the Russian Military Medical Academy. 2022;24(2):267–276. (In Russ.)

[2] Азаров И.И., Овчинников Д.В., Кузин А.А., и др. Оценка поствакцинального коллективного иммунитета против новой коронавирусной инфекции (COVID-19) среди военнослужащих Вооруженных сил Российской Федерации // Вестник Российской военно-медицинской академии. 2022. Т. 24, № 2. С. 267–276.

[3] Ivchenko EV, Kotiv BN, Ovchinnikov DV, Butsenko SA. Results of the work of the Research Institute of Problems of new coronavirus infection of the Military Medical Academy for 2020–2021. Bulletin of the Russian Military Medical Academy. 2021;23(4):93–104. (In Russ.)

[4] Ивченко Е.В., Котив Б.Н., Овчинников Д.В., Буценко С.А. Результаты работы научно-исследовательского института проблем новой коронавирусной инфекции Военно-медицинской академии за 2020–2021 гг. // Вестник Российской Военно-медицинской академии. 2021. Т. 23, № 4. С. 93–104.

[5] Kryukov EV, Trishkin DV, Salukhov VV, Ivchenko EV. Experience of military medicine in the fight against a new coronavirus infection. Bulletin of the Russian Academy of Sciences. 2022;92(7):699–706. (In Russ.)

[6] Крюков Е.В., Тришкин Д.В., Салухов В.В., Ивченко Е.В. Опыт военной медицины в борьбе с новой коронавирусной инфекцией // Вестник Российской академии наук. 2022. Т. 92, № 7. С. 699–706.

[7] Kryukov EV, Trishkin DV, Ivanov AM, et al. Epidemiological study of collective immunity against a new coronavirus infection among different groups of military personnel. Bulletin of the Russian Academy of Medical Sciences. 2021;76(6):661–668. (In Russ.)

[8] Крюков Е.В., Тришкин Д.В., Иванов А.М., и др. Эпидемиологическое исследование коллективного иммунитета против новой коронавирусной инфекции среди разных групп военнослужащих // Вестник Российской академии медицинских наук. 2021. Т. 76, № 6. С. 661–668.

[9] Minnullin TI, Stepanov AV, Chepur SV, et al. Immunological aspects of coronavirus SARS-COV-2 infection. Bulletin of the Russian Military Medical Academy. 2021;2(74):187–198. (In Russ.)

[10] Миннуллин Т.И., Степанов А.В., Чепур С.В., и др. Иммунологические аспекты поражения коронавирусом SARS-COV-2 // Вестник Российской Военно-медицинской академии. 2021. Т. 2, № 74. С. 187–198.

[11] Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. DOI: 10.1016/S0140-6736(20)30211-7

[12] Chen N., Zhou M., Dong X., et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study // Lancet. 2020. Vol. 395, No. 10223. P. 507–513. DOI: 10.1016/S0140-6736(20)30211-7

[13] Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. DOI: 10.1016/S0140-6736(20)30183-5

[14] Huang C., Wang Y., Li X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China // Lancet. 2020. Vol. 395, No. 10223. P. 497–506. DOI: 10.1016/S0140-6736(20)30183-5

[15] Bilichenko TN. Risk factors, immunological mechanisms and biological markers of severe COVID-19 (research review). Medical Review. 2021;(5):237–244. (In Russ.)

[16] Биличенко Т.Н. Факторы риска, иммунологические механизмы и биологические маркеры тяжелого течения COVID-19 (обзор исследований) // Медицинское обозрение. 2021. № 5. С. 237–244.

[17] Channappanavar R, Fehr A, Vijay R, et al. Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice. Cell Host Microbe. 2016;19(2):181–193. DOI: 10.1016/j.chom.2016.01.007

[18] Channappanavar R., Fehr A., Vijay R., et al. Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice // Cell Host Microbe. 2016. Vol. 19, No. 2. P. 181–193. DOI: 10.1016/j.chom.2016.01.007

[19] Huang KJ, Su IJ, Theron M, et al. An interferon-gamma-related cytokine storm in SARS patients. J Med Virol. 2005;75(2):185–194. DOI: 10.1002/jmv.20255

[20] Huang K.J., Su I.J., Theron M., et al. An interferon-gamma-related cytokine storm in SARS patients // J. Med. Virol. 2005. Vol. 75, No. 2. P. 185–194. DOI: 10.1002/jmv.20255

[21] Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med. 2020;8(4):420–422. DOI: 10.1016/S2213-2600(20)30076-X

[22] Xu Z., Shi L., Wang Y., et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome // Lancet Respir. Med. 2020. Vol. 8, No. 4. P. 420–422. DOI: 10.1016/S2213–2600(20)30076-X

[23] Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis. 2020;71(15):762–768. DOI: 10.1093/cid/ciaa248

[24] Qin C., Zhou L., Hu Z., et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China // Clin. Infect. Dis. 2020. Vol. 71, No. 15. P. 762–768. DOI: 10.1093/cid/ciaa248

RIGHTS & PERMISSIONS

Eco-Vector